will compounded semaglutide be banned Now that shortages of and tirzepatide are resolved, you may wonder if GLP-1s are going away. Here's why they haven't disappeared entirely. 🔗 Check GoodRx for savings at the link Fifth Circuit probes FDA ban

Our team provides customized meal plans and fitness recommendations to complement your GLP-1 weight loss journey

Novo has advanced amycretin to Phase 3 trials starting in 2026

Mini glossary: key hair and medication terms Retatrutide: An investigational triple hormone receptor agonist (GLP-1, GIP, glucagon) being studied for obesity and metabolic disease

There is only failure in pushing through severe symptoms until you quit entirely

In the interim, evidence-based prescription of GLP-1 RAs in persons with SMI-SUD holds promise to improve their health and well-being and possibly reduce the excess mortality, which is a strategic imperative in psychiatry

Furthermore, introduction of these agents into clinical practice has been accompanied by a shift in the focus of diabetes care from a glucose-centric to a cardiorenal risk-centric approach